HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

被引:5
作者
Lurain, Kathryn A. [1 ]
Ramaswami, Ramya [1 ]
Krug, Laurie T. [1 ]
Whitby, Denise [2 ]
Ziegelbauer, Joseph M. [1 ]
Wang, Hao-Wei [3 ]
Yarchoan, Robert [1 ]
机构
[1] Ctr Canc Res, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA
[2] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Viral Oncol Sect, Leidos Biomed Res, Frederick, MD USA
[3] NCI, Lab Pathol, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
EBV; KSHV; Kaposi; HIV; AIDS; lymphoma; gammaherpesvirus; Castleman; PRIMARY EFFUSION LYMPHOMA; MULTICENTRIC CASTLEMAN DISEASE; PEGYLATED LIPOSOMAL DOXORUBICIN; PROTEIN-COUPLED RECEPTOR; NF-KAPPA-B; ACTIVE ANTIRETROVIRAL THERAPY; POSITRON-EMISSION-TOMOGRAPHY; CLASSICAL HODGKIN LYMPHOMA; FLICE INHIBITORY PROTEIN; NUCLEAR ANTIGEN;
D O I
10.1128/cmr.00022-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Within weeks of the first report of acquired immunodeficiency syndrome (AIDS) in 1981, it was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin tumor in the USA. It soon became apparent that AIDS was also associated with an increased incidence of high-grade lymphomas caused by Epstein-Barr virus (EBV). The association of AIDS with KS remained a mystery for more than a decade until Kaposi sarcoma-associated herpesvirus (KSHV) was discovered and found to be the cause of KS. KSHV was subsequently found to cause several other diseases associated with AIDS and human immunodeficiency virus (HIV) infection. People living with HIV/AIDS continue to have an increased incidence of certain cancers, and many of these cancers are caused by EBV and/or KSHV. In this review, we discuss the epidemiology, virology, pathogenesis, clinical manifestations, and treatment of cancers caused by EBV and KSHV in persons living with HIV.
引用
收藏
页数:48
相关论文
共 424 条
  • [1] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
    Alizadeh, AA
    Eisen, MB
    Davis, RE
    Ma, C
    Lossos, IS
    Rosenwald, A
    Boldrick, JG
    Sabet, H
    Tran, T
    Yu, X
    Powell, JI
    Yang, LM
    Marti, GE
    Moore, T
    Hudson, J
    Lu, LS
    Lewis, DB
    Tibshirani, R
    Sherlock, G
    Chan, WC
    Greiner, TC
    Weisenburger, DD
    Armitage, JO
    Warnke, R
    Levy, R
    Wilson, W
    Grever, MR
    Byrd, JC
    Botstein, D
    Brown, PO
    Staudt, LM
    [J]. NATURE, 2000, 403 (6769) : 503 - 511
  • [2] Deletion of Kaposi's Sarcoma-Associated Herpesvirus FLICE Inhibitory Protein, vFLIP, from the Viral Genome Compromises the Activation of STAT1-Responsive Cellular Genes and Spindle Cell Formation in Endothelial Cells
    Alkharsah, Khaled R.
    Singh, Vivek Vikram
    Bosco, Raffaella
    Santag, Susann
    Grundhoff, Adam
    Konrad, Andreas
    Stuerzl, Michael
    Wirth, Dagmar
    Dittrich-Breiholz, Oliver
    Kracht, Michael
    Schulz, Thomas F.
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (19) : 10375 - 10388
  • [3] Epstein-Barr virus provides a new paradigm: A requirement for the immediate inhibition of apoptosis
    Altmann, M
    Hammerschmidt, W
    [J]. PLOS BIOLOGY, 2005, 3 (12) : 2148 - 2157
  • [4] The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element
    An, JB
    Lichtenstein, AK
    Brent, G
    Rettig, MB
    [J]. BLOOD, 2002, 99 (02) : 649 - 654
  • [5] Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
    Anastasiadou, Eleni
    Stroopinsky, Dina
    Alimperti, Stella
    Jiao, Alan L.
    Pyzer, Athalia R.
    Cippitelli, Claudia
    Pepe, Giuseppina
    Severa, Martina
    Rosenblatt, Jacalyn
    Etna, Marilena P.
    Rieger, Simone
    Kempkes, Bettina
    Coccia, Eliana M.
    Sui, Shannan J. Ho
    Chen, Christopher S.
    Uccini, Stefania
    Avigan, David
    Faggioni, Alberto
    Trivedi, Pankaj
    Slack, Frank J.
    [J]. LEUKEMIA, 2019, 33 (01) : 132 - 147
  • [6] Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma
    Anderton, E.
    Yee, J.
    Smith, P.
    Crook, T.
    White, R. E.
    Allday, M. J.
    [J]. ONCOGENE, 2008, 27 (04) : 421 - 433
  • [7] Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-Related primary CNS lymphoma
    Antinori, A
    De Rossi, G
    Ammassari, A
    Cingolani, A
    Murri, R
    Di Giuda, D
    De Luca, A
    Pierconti, F
    Tartaglione, T
    Scerrati, M
    Larocca, LM
    Ortona, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 554 - 560
  • [8] Kaposi's sarcoma
    Antman, K
    Chang, Y
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) : 1027 - 1038
  • [9] Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus
    Aoki, Y
    Narazaki, M
    Kishimoto, T
    Tosato, G
    [J]. BLOOD, 2001, 98 (10) : 3042 - 3049
  • [10] Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders
    Aoki, Y
    Yarchoan, R
    Wyvill, K
    Okamoto, S
    Little, RF
    Tosato, G
    [J]. BLOOD, 2001, 97 (07) : 2173 - 2176